Condition: Rhinovirus
Interventions: Drug: BTA798; Drug: Placebo
Sponsor: Biota Scientific Management Pty Ltd
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
A Randomized, Double-blind Study to Evaluate the Dosing of AMG 827 for Subjects With Inadequately Controlled Asthma
Condition: Asthma
Interventions: Drug: AMG 827; Drug: AMG 827; Drug: AMG 827; Drug: Placebo
Sponsor: Amgen
Not yet recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Inhaled Steroids and Control of Severe Asthma
Condition: Severe Persistent Asthma
Intervention:
Sponsors: University of Giessen; Activaero GmbH; Hessen Agentur
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Dynamic Contrast Enhanced Magnetic Resonance Perfusion Imaging in Congenital Heart Disease and Lung Disease
Conditions: Heart Disease; Cystic Fibrosis; Asthma
Interventions: Procedure: Phase contrast flow velocity mapping (PC); Procedure: Dynamic contrast-enhanced magnetic resonance imaging
Sponsor: The Hospital for Sick Children
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Pharmacokinetics in Adolescents
Condition: Asthma
Intervention: Drug: AZD1981 100 mg twice daily for 61/2 days
Sponsor: AstraZeneca
Not yet recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Effect of a Component of Fish Oil on Exercise-Induced Bronchoconstriction and Airway Inflammation in Asthma
Condition: Asthma
Interventions: Dietary Supplement: Docosahexaenoic Acid; Dietary Supplement: Placebo Docosahexaenoic Acid
Sponsors: Indiana University; Indiana University Department of Kinesiology
Not yet recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Comparative Study of Lung Bioavailability of HFA-Seretide Via Current Spacer Devices in Healthy Volunteers
Condition: Asthma
Interventions: Drug: Seretide 250(8puffs) via Evohaler actuator; Drug: Seretide 250 (8 puffs)/placebo via Volumatic spacer; Drug: Seretide 250/placebo 8 puffs via Aerochamber Plus spacer; Drug: Seretide 250/placebo via Synchro-Breathe
Sponsor: University of Dundee
Completed – verified December 2009
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
A Phase 1 Study of CNTO 3157 in Healthy Volunteers and Patients With Asthma
Condition: Asthma
Interventions: Biological: CNTO 3157 or placebo; Biological: CNTO 3157 or placebo; Biological: CNTO 3157 or placebo; Biological: CNTO 3157 or placebo; Biological: CNTO 3157 or placebo; Biological: CNTO 3157 or placebo; Biological: CNTO 3157 or placebo; Biological: CNTO 3157 or placebo
Sponsor: Centocor, Inc.
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Optimal Albuterol Regimens for Acute Asthma Exacerbations: DBRCT Pilot Study
Condition: Moderate and Severe Acute Asthma Exacerbations in Pediatric Patients
Intervention: Drug: Albuterol
Sponsors: Vanderbilt University; National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Pulmicort Turbuhaler 100/200 Specific Clinical Experience Investigation
Condition: Bronchial Asthma
Intervention:
Sponsor: AstraZeneca
Not yet recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days